BritLofex lofexidine: Phase III started

WorldMeds began the double-blind, placebo-controlled, U.S. Phase III USWM-001 trial in 264 opiate-dependent patients. In November 2003, WorldMeds received U.S. rights to the compound from Britannia, w...